Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anavex appoints Robert Chisholm CFO

This article was originally published in Scrip

Executive Summary

Anavex Life Sciences, a Vancouver-based pharmaceutical company developing novel drug candidates, has appointed Robert Chisholm CFO. Mr Chisholm has served on the Anavex board since May 2011 and will remain a director in addition to his new role. Mr Chisholm has been CFO of both Savary Capital and OMT since March 2011 and July 2011 respectively, and is currently CFO of TMT Resources, Emprise Capital Corp and Ripper Oil and Gas. He also serves on the board of Rare Earth Industries. Additionally, Harvey Lalach has resigned as a director and officer of the company. Mr Chisholm will serve as interim president.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC017971

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel